Pediarix is a combination vaccine that protects infants against five diseases in a single shot: diphtheria, tetanus, pertussis (whooping cough), hepatitis B, and polio. Manufactured by GlaxoSmithKline and approved by the FDA, it combines what would otherwise be three separate injections into one, reducing the total number of shots a baby receives during their first six months.
Five Diseases in One Shot
Pediarix bundles together three vaccines that infants need on the same schedule:
- DTaP, which covers diphtheria, tetanus, and pertussis (whooping cough)
- IPV, the inactivated poliovirus vaccine
- Hepatitis B vaccine, which protects against the virus that causes serious liver disease
Each of these diseases posed major threats to children before routine vaccination. Pertussis can cause severe coughing fits and breathing problems in newborns. Diphtheria creates a thick coating in the throat that can block the airway. Tetanus causes painful muscle stiffness and lockjaw. Polio can lead to permanent paralysis. Hepatitis B can become a chronic infection that damages the liver over decades. Pediarix addresses all five with a single injection rather than three.
When It’s Given
Pediarix is given as a three-dose series at 2, 4, and 6 months of age. The minimum age for the first dose is 6 weeks. It is not approved for children 7 years of age or older, so it’s strictly an infant and early childhood vaccine.
Most infants still receive a separate hepatitis B vaccine at birth, before the Pediarix series begins. The Pediarix doses at 2, 4, and 6 months then complete the hepatitis B series while simultaneously covering DTaP and polio on the recommended schedule. Children will still need additional DTaP and polio boosters later in childhood, but Pediarix handles the primary infant series for all five diseases.
How It Compares to Separate Vaccines
Clinical trials directly compared the immune response in infants who received Pediarix against infants who got the three component vaccines as separate injections. The combination vaccine produced antibody levels that were non-inferior to the separate vaccines across the board, meaning children were equally well protected either way.
For several of the antigens, Pediarix actually produced higher average antibody levels than the separate vaccines. Antibodies against the hepatitis B surface antigen, for example, averaged 1,032 mIU/mL in the Pediarix group compared to 615 mIU/mL in the group that received individual vaccines. The pertussis antibody responses followed a similar pattern. The percentage of children reaching protective antibody levels was the same in both groups, confirming that the combination approach works just as well as giving each vaccine individually.
Common Side Effects
The side effects of Pediarix are similar to what you’d expect from any of the individual vaccines it contains. The most common reactions are mild and temporary: redness, swelling, or tenderness at the injection site, fussiness, drowsiness, and low-grade fever. These typically appear within a day or two of the shot and resolve on their own.
Because Pediarix contains the same active ingredients as the separate vaccines, it doesn’t introduce new or different side effects. The main practical difference is fewer needle sticks per visit, which means less distress for the baby and a simpler appointment overall. Some studies have noted slightly higher rates of fever with combination vaccines compared to giving components separately, but the difference is small and the fevers are generally mild.
Who Should Not Receive Pediarix
Pediarix should not be given to infants who have had a severe allergic reaction to a previous dose of any of its component vaccines, including DTaP, hepatitis B, or polio vaccine. It’s also not appropriate for babies who experienced a serious neurological condition, such as encephalopathy (brain swelling), within seven days of a prior pertussis-containing vaccine.
The vaccine is approved only for children between 6 weeks and 6 years of age. It cannot be used for the birth dose of hepatitis B, since the minimum age is 6 weeks. Children 7 and older who still need these vaccines will receive age-appropriate formulations instead.
Why Combination Vaccines Matter
By the time a child is 2 years old, the recommended immunization schedule includes protection against more than a dozen diseases. Combination vaccines like Pediarix reduce the total number of injections, which makes it easier to stay on schedule and means fewer office visits. For the infant, it means less pain. For parents, it means fewer appointments to juggle.
The immune system handles combination vaccines the same way it handles individual ones. Infants encounter thousands of foreign substances every day, and the antigens in a five-in-one vaccine represent a tiny fraction of what their immune system processes routinely. The clinical data confirms this: children who receive Pediarix build the same level of protection as those who get each vaccine separately.